Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309 |
Resumo: | Introduction: Yellow fever is a vector-borne disease in sub-Saharan Africa and tropical South America regions which is preventable by an effective and safe vaccine. In some cases, it may cause serious adverse effects and should therefore be prescribed only to individuals at risk of exposure to the yellow fever virus or those traveling to countries requiring proof of vaccination. The aim of this study was to analyze the prescriptions of yellow fever vaccine, based on travel destination and type of referring consultation, according to the international recommendations of the World Health Organization.Material and Methods: The database of the International Vaccination Centre of the International Vaccination Centre of the Loures-Odivelas Health Centre Group was used to analyze data concerning the year of 2016. Travelers who were prescribed and administered the yellow fever vaccine were grouped based on travel destination and type of referring consultation (travelers’ medical consultations or non-specialist consultations).Results: A total of 517 yellow fever vaccines were administered, with the highest proportion in female (53%) and in individuals aged 40 - 49 years (20.7%). One hundred and thirteen (22.6%) of the 499 individuals with known-destinations were travelling to non-endemic/non-epidemic countries and a greater proportion of those were prescribed in non-specialist consultations (27.3%) than in travel medicine consultations (8.8%).Discussion/Conclusion: The highest percentage of yellow fever vaccines that were administered to individuals travelling to non-endemic/non-epidemic countries were prescribed in non-specialist consultations. |
id |
RCAP_6160dc5a3dc28284d082df91bcf4cc95 |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/10309 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre GroupPrescrição da Vacina Contra a Febre Amarela: Experiência do Centro de Vacinação Internacional do Agrupamento de Centros de Saúde Loures-OdivelaImmunization ProgramsPortugalTravelYellow Fever VaccinePortugalProgramas de ImunizaçãoVacina contra Febre AmarelaViagemIntroduction: Yellow fever is a vector-borne disease in sub-Saharan Africa and tropical South America regions which is preventable by an effective and safe vaccine. In some cases, it may cause serious adverse effects and should therefore be prescribed only to individuals at risk of exposure to the yellow fever virus or those traveling to countries requiring proof of vaccination. The aim of this study was to analyze the prescriptions of yellow fever vaccine, based on travel destination and type of referring consultation, according to the international recommendations of the World Health Organization.Material and Methods: The database of the International Vaccination Centre of the International Vaccination Centre of the Loures-Odivelas Health Centre Group was used to analyze data concerning the year of 2016. Travelers who were prescribed and administered the yellow fever vaccine were grouped based on travel destination and type of referring consultation (travelers’ medical consultations or non-specialist consultations).Results: A total of 517 yellow fever vaccines were administered, with the highest proportion in female (53%) and in individuals aged 40 - 49 years (20.7%). One hundred and thirteen (22.6%) of the 499 individuals with known-destinations were travelling to non-endemic/non-epidemic countries and a greater proportion of those were prescribed in non-specialist consultations (27.3%) than in travel medicine consultations (8.8%).Discussion/Conclusion: The highest percentage of yellow fever vaccines that were administered to individuals travelling to non-endemic/non-epidemic countries were prescribed in non-specialist consultations.Introdução: A febre amarela é uma doença de transmissão vetorial que ocorre na África Subsaariana e na América do Sul tropical, e é evitável por uma vacina eficaz e segura. Nalguns casos pode causar efeitos adversos graves, devendo ser prescrita apenas a indivíduos em risco de exposição ao vírus ou que viajem para países que exigem prova de vacinação. O objetivo deste estudo foi analisar a prescrição da vacina contra a febre amarela, de acordo com o destino da viagem e o tipo de consulta de referenciação, segundo as recomendações internacionais da Organização Mundial de Saúde.Material e Métodos: Foi analisada a base de dados existente no Centro de Vacinação Internacional do Agrupamento de Centros de Saúde Loures-Odivelas, referente a 2016. Foram estudados os registos dos viajantes a quem foi prescrita e administrada a vacina contra a febre amarela, de acordo com o destino da viagem e o tipo de consulta de referenciação (consulta de medicina do viajante ou consulta não especializada).Resultados: Foram administradas no total 517 vacinas contra a febre amarela, em maior proporção em indivíduos do sexo feminino (53%) e em indivíduos dos 40 aos 49 anos de idade (20,7%). Dos 499 indivíduos que tinham destino conhecido, 113 (22,6%) tinham como destino países não endémicos/não epidémicos, com uma maior proporção de prescrições em contexto de consultas não especializadas (27,3%) do que em consultas de medicina do viajante (8,8%).Discussão/Conclusão: A maior percentagem de vacinas contra a febre amarela administradas a indivíduos que tiveram como destino países não endémicos/não epidémicos foram prescritas numa consulta não especializada.Ordem dos Médicos2018-12-28info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/pdfapplication/pdfimage/x-ms-bmpimage/tiffapplication/mswordapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309oai:ojs.www.actamedicaportuguesa.com:article/10309Acta Médica Portuguesa; Vol. 31 No. 12 (2018): December; 724-729Acta Médica Portuguesa; Vol. 31 N.º 12 (2018): Dezembro; 724-7291646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/5560https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/6065https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/9998https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10113https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10243https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10244https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10245https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10707Direitos de Autor (c) 2018 Acta Médica Portuguesainfo:eu-repo/semantics/openAccessMartinho, ClarisseLopes, DavidBastos, LucianaEsteves, Hugo2022-12-20T11:05:56Zoai:ojs.www.actamedicaportuguesa.com:article/10309Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:52.109327Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group Prescrição da Vacina Contra a Febre Amarela: Experiência do Centro de Vacinação Internacional do Agrupamento de Centros de Saúde Loures-Odivela |
title |
Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group |
spellingShingle |
Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group Martinho, Clarisse Immunization Programs Portugal Travel Yellow Fever Vaccine Portugal Programas de Imunização Vacina contra Febre Amarela Viagem |
title_short |
Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group |
title_full |
Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group |
title_fullStr |
Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group |
title_full_unstemmed |
Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group |
title_sort |
Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group |
author |
Martinho, Clarisse |
author_facet |
Martinho, Clarisse Lopes, David Bastos, Luciana Esteves, Hugo |
author_role |
author |
author2 |
Lopes, David Bastos, Luciana Esteves, Hugo |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Martinho, Clarisse Lopes, David Bastos, Luciana Esteves, Hugo |
dc.subject.por.fl_str_mv |
Immunization Programs Portugal Travel Yellow Fever Vaccine Portugal Programas de Imunização Vacina contra Febre Amarela Viagem |
topic |
Immunization Programs Portugal Travel Yellow Fever Vaccine Portugal Programas de Imunização Vacina contra Febre Amarela Viagem |
description |
Introduction: Yellow fever is a vector-borne disease in sub-Saharan Africa and tropical South America regions which is preventable by an effective and safe vaccine. In some cases, it may cause serious adverse effects and should therefore be prescribed only to individuals at risk of exposure to the yellow fever virus or those traveling to countries requiring proof of vaccination. The aim of this study was to analyze the prescriptions of yellow fever vaccine, based on travel destination and type of referring consultation, according to the international recommendations of the World Health Organization.Material and Methods: The database of the International Vaccination Centre of the International Vaccination Centre of the Loures-Odivelas Health Centre Group was used to analyze data concerning the year of 2016. Travelers who were prescribed and administered the yellow fever vaccine were grouped based on travel destination and type of referring consultation (travelers’ medical consultations or non-specialist consultations).Results: A total of 517 yellow fever vaccines were administered, with the highest proportion in female (53%) and in individuals aged 40 - 49 years (20.7%). One hundred and thirteen (22.6%) of the 499 individuals with known-destinations were travelling to non-endemic/non-epidemic countries and a greater proportion of those were prescribed in non-specialist consultations (27.3%) than in travel medicine consultations (8.8%).Discussion/Conclusion: The highest percentage of yellow fever vaccines that were administered to individuals travelling to non-endemic/non-epidemic countries were prescribed in non-specialist consultations. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-12-28 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309 oai:ojs.www.actamedicaportuguesa.com:article/10309 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/10309 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/5560 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/6065 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/9998 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10113 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10243 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10244 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10245 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10707 |
dc.rights.driver.fl_str_mv |
Direitos de Autor (c) 2018 Acta Médica Portuguesa info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Direitos de Autor (c) 2018 Acta Médica Portuguesa |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf image/x-ms-bmp image/tiff application/msword application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 31 No. 12 (2018): December; 724-729 Acta Médica Portuguesa; Vol. 31 N.º 12 (2018): Dezembro; 724-729 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130648388042752 |